JP Morgan Chase’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

JP Morgan Chase’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$91.4M	Buy	+2,687,943	New	+$74.6M	0.01%	1094
2021 Q4	–	Sell	-295	Closed	-$127K	–	6691
2021 Q3	$127K	Sell	295 -132	-31%	-$60.5K	﹤0.01%	5449
2021 Q2	$233K	Sell	427 -331	-44%	-$145K	﹤0.01%	5154
2021 Q1	$296K	Buy	758 +122	+19%	+$64.1K	﹤0.01%	4973
2020 Q4	$273K	Buy	636 +292	+85%	+$139K	﹤0.01%	4692
2020 Q3	$332K	Buy	344 +290	+537%	+$232K	﹤0.01%	4160
2020 Q2	$44K	Hold	54	–	–	﹤0.01%	4866
2020 Q1	$20K	Sell	54 -7	-11%	-$3.5K	﹤0.01%	4948
2019 Q4	$23K	Buy	61 +2	+3%	+$1.31K	﹤0.01%	5298
2019 Q3	$101K	Buy	59 +6	+11%	+$9.07K	﹤0.01%	4900
2019 Q2	$83K	Buy	+53	New	+$105K	﹤0.01%	4997

Other funds holding KRSA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return

General Atlantic New York $2.48B AUM 19.88% 1-Year Est. Return

Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return

Remedium Capital Partners Fort Lauderdale, Florida $274M AUM 288.41% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return

Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

JP Morgan Chase's KRSA Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2026: 2,687,943 shares worth $91.4M. The stake represents 0.01% of the portfolio and ranks #1094 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in KRSA as recently as Q3 2021.

JP Morgan Chase first reported a position in KRSA in Q2 2019 and has held it in 11 quarters since. 24 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.

JP Morgan Chase held 2,687,943 shares of Korsana Biosciences, Inc. Common Stock worth $91.4M as of Q3 2026.
Korsana Biosciences, Inc. Common Stock was a new JP Morgan Chase position in Q3 2026.
Korsana Biosciences, Inc. Common Stock made up 0.01% of JP Morgan Chase's portfolio in Q3 2026, its #1094 holding.
JP Morgan Chase first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and has held it in 11 quarters since.
24 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.